1 |
Forsythe WI, Gillies D, Sills MA. Propanolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol 1984;26(6):737-41.
DOI
|
2 |
Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med 2017;376(2):115-24
DOI
|
3 |
Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45(10):1304-12.
DOI
|
4 |
Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123(3):924-34.
DOI
|
5 |
Rho YI, Chung HJ, Lee KH, et al. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache 2012;52(4):592-9.
DOI
|
6 |
Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache 2013;53(3):427-36.
DOI
|
7 |
Ashina M. Migraine. N Engl J Med 2020;383(19):1866-76.
DOI
|
8 |
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):954-76.
DOI
|
9 |
Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache 1977;17(4):173-80.
DOI
|
10 |
Lee LH, Olness KN. Clinical and demographic characteristics of migraine in urban children. Headache 1997;37(5):269-76.
DOI
|
11 |
Eun SH, Eun BL. Headaches in children and adolescents: diagnosis and treatment. Korean J Pediatr 2006:49(4);354-63.
DOI
|
12 |
Patniyot I, Qubty W. Short-term treatment of migraine in children and adolescents. JAMA Pediatr 2020;174(8):789-90.
DOI
|
13 |
Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2019;93(11):487-99.
DOI
|
14 |
Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015;55(1):21-34.
DOI
|
15 |
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventative therapy. Neurology 2007;68(5):343-9.
DOI
|
16 |
KH Lee. Recent updates on treatment for pediatric migraine. J Korean Med Assoc 2017:60(2):118-25.
DOI
|
17 |
Shamliyan TA, Kane RL, Ramakrishnan R, Taylor FR. Episodic migraines in children: limited evidence on preventive pharmacological treatments. J Child Neurol 2013;28(10):1320-41.
DOI
|
18 |
Thorlund K, Sun-Edelstein C, Druyts E, et al. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17(1):107.
DOI
|
19 |
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48(8):1157-68.
DOI
|
20 |
O'Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother 2012;13(7):959-66.
DOI
|
21 |
Kim J, Lee S, Rhew K. Association between Gastrointestinal Diseases and Migraine. Int J Environ Res Public Health 2022;19(7):4018.
DOI
|
22 |
Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 2012;32(10):750-65.
DOI
|
23 |
Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 1992;34(12):1095-101.
DOI
|
24 |
El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr 2013;167(3):250-8.
DOI
|
25 |
Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40(7):539-49.
DOI
|
26 |
Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120(2):390-6.
DOI
|
27 |
Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: A systematic review of medication trials. Pediatrics 2005;116(2):e295-302.
DOI
|
28 |
Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988;8(1):1-6.
DOI
|
29 |
Genizi J, Lahoud D, Cohen R. Migraine abortive treatment in children and adolescents in Israel. Sci Rep 2022;12(1):7418.
DOI
|
30 |
Lewis DW, Winner P. The pharmacological treatment options for pediatric migraine: An evidence-based appraisal. NeuroRx 2006;3(2):181-91.
DOI
|
31 |
Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4(4):CD005220.
|
32 |
Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974;50(1):109-15.
DOI
|